Movement Alert｜WUXI XDC Rises 4.34% in Regular Trading, Interim Results Expectations Warming Up as Multiple Banks Turn Bullish

Market Focus

Aug 06

On August 6, WUXI XDC rose 4.34% in regular trading, trading at 56.25 HKD/share, with turnover of 65.62 million HKD.

On the news front, the company is scheduled to hold a board meeting on August 24 to review its interim results for the first half of the year, with market expectations for the global ADC outsourcing leader's high-growth trajectory continuing to build. CLSA recently raised its target price to 82.6 HKD and maintained an \"outperform\" rating, forecasting revenue and adjusted net profit growth to exceed guidance. Daiwa initiated coverage with a \"buy\" rating and a 78 HKD target price, listing the company as a top pick in the China CXO sector.

Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with Genscript Bio up 4.91% and WuXi Bio up 2.46%. Global biotech financing recovery and robust ADC R&D investment are driving early positioning by institutional capital ahead of interim earnings disclosure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1167505218"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167505218\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1167505218?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167505218","market":"us","top_or_hot":-1,"title":"Movement Alert｜WUXI XDC Rises 4.34% in Regular Trading, Interim Results Expectations Warming Up as Multiple Banks Turn Bullish","media":"Market Focus","content":"<p><p>On August 6, WUXI XDC rose 4.34% in regular trading, trading at 56.25 HKD/share, with turnover of 65.62 million HKD.</p><p>On the news front, the company is scheduled to hold a board meeting on August 24 to review its interim results for the first half of the year, with market expectations for the global ADC outsourcing leader's high-growth trajectory continuing to build. CLSA recently raised its target price to 82.6 HKD and maintained an \\\"outperform\\\" rating, forecasting revenue and adjusted net profit growth to exceed guidance. Daiwa initiated coverage with a \\\"buy\\\" rating and a 78 HKD target price, listing the company as a top pick in the China CXO sector.</p><p>Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with Genscript Bio up 4.91% and WuXi Bio up 2.46%. Global biotech financing recovery and robust ADC R&D investment are driving early positioning by institutional capital ahead of interim earnings disclosure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WUXI XDC Rises 4.34% in Regular Trading, Interim Results Expectations Warming Up as Multiple Banks Turn Bullish</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WUXI XDC Rises 4.34% in Regular Trading, Interim Results Expectations Warming Up as Multiple Banks Turn Bullish\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-06 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 6, WUXI XDC rose 4.34% in regular trading, trading at 56.25 HKD/share, with turnover of 65.62 million HKD.</p><p>On the news front, the company is scheduled to hold a board meeting on August 24 to review its interim results for the first half of the year, with market expectations for the global ADC outsourcing leader's high-growth trajectory continuing to build. CLSA recently raised its target price to 82.6 HKD and maintained an \\\"outperform\\\" rating, forecasting revenue and adjusted net profit growth to exceed guidance. Daiwa initiated coverage with a \\\"buy\\\" rating and a 78 HKD target price, listing the company as a top pick in the China CXO sector.</p><p>Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with Genscript Bio up 4.91% and WuXi Bio up 2.46%. Global biotech financing recovery and robust ADC R&D investment are driving early positioning by institutional capital ahead of interim earnings disclosure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1167505218","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167505218","pubTimestamp":1785981114,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 6, WUXI XDC rose 4.34% in regular trading, trading at 56.25 HKD/share, with turnover of 65.62 million HKD.On the news front, the company is scheduled to hold a board meeting on August 24 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"走势提醒|无锡XDC常规交易上涨4.34%，多家银行转向看涨，中期业绩预期升温","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On August 6, WUXI XDC rose 4.34% in regular trading, trading at 56.25 HKD/share, with turnover of 65.62 million HKD.On the news front, the company is scheduled to hold a board meeting on August 24 to review its interim results for the first half of the year, with market expectations for the global ADC outsourcing leader's high-growth trajectory continuing to build. CLSA recently raised its target price to 82.6 HKD and maintained an \\\"outperform\\\" rating, forecasting revenue and adjusted net profit growth to exceed guidance. Daiwa initiated coverage with a \\\"buy\\\" rating and a 78 HKD target price, listing the company as a top pick in the China CXO sector.Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with Genscript Bio up 4.91% and WuXi Bio up 2.46%. Global biotech financing recovery and robust ADC R&D investment are driving early positioning by institutional capital ahead of interim earnings disclosure.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}